Jim Wassil - 01 Jul 2022 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role: Chief Operating Officer
Signature: Jim Wassil, by /s/ Ron A. Metzger, Attorney-in-Fact
Issuer symbol: PCVX
Transactions as of: 01 Jul 2022
Net transactions value: -$54,824
Form type: 4
Filing time: 06 Jul 2022, 16:36:11 UTC
Previous filing: 14 Jun 2022
Next filing: 19 Aug 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PCVX	Common Stock	Options Exercise	$6,776	+2,800	+6.3%	$2.42^*	47,306	01 Jul 2022	Direct	F1
transaction	PCVX	Common Stock	Sale	$61,600	-2,800	-5.9%	$22.00	44,506	01 Jul 2022	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PCVX	Stock Option (right to buy)	Options Exercise	$0	-2,800	-1.2%	$0.000000	230,326	01 Jul 2022	Common Stock	2,800	$2.42	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 1,562 shares acquired under the Issuer's Employee Stock Purchase Plan on May 17, 2022.
F2	The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F3	1/4 of the shares subject to the option vested on December 1, 2020, and 1/48 of the shares vest monthly thereafter.